Q4 2021 Holdings
Filed 2022-02-14 | 376 holdings | $24.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Conocophillips(COP) | COM | 20825C104 | $2.3M | 31,605 | 9.3% |
| Crown Castle Intl Corp New(CCI) | COM | 22822V101 | $2.2M | 10,495 | 9.0% |
| Cubesmart(CUBE) | COM | 229663109 | $2.2M | 38,321 | 8.9% |
| DT Midstream Inc(DTM) | COMMON STOCK | 23345M107 | $2.1M | 44,727 | 8.8% |
| Cousins Pptys Inc(CUZ) | COM NEW | 222795502 | $2.1M | 52,445 | 8.7% |
| DTE Energy Co(DTE) | COM | 233331107 | $2.1M | 17,264 | 8.5% |
| Barrick Gold Corp(ABX) | COM | 067901108 | $2.0M | 106,659 | 8.3% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $472.0K | 20,653 | 1.9% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $451.0K | 32,542 | 1.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $396.0K | 4,486 | 1.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $387.0K | 1,612 | 1.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $379.0K | 11,541 | 1.6% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $377.0K | 16,172 | 1.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $366.0K | 2,722 | 1.5% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $362.0K | 1,336 | 1.5% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $346.0K | 1,344 | 1.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $340.0K | 2,003 | 1.4% |
| Crescent Cap BDC Inc(CCAP) | COM | 225655109 | $328.0K | 18,653 | 1.3% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $227.0K | 10,965 | 0.9% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $205.0K | 2,494 | 0.8% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $202.0K | 5,350 | 0.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $202.0K | 4,425 | 0.8% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $193.0K | 3,166 | 0.8% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $191.0K | 6,726 | 0.8% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $183.0K | 20,481 | 0.8% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $180.0K | 5,589 | 0.7% |
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $178.0K | 4,803 | 0.7% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $178.0K | 12,482 | 0.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $177.0K | 20,610 | 0.7% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $176.0K | 46,931 | 0.7% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $171.0K | 11,487 | 0.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $169.0K | 4,382 | 0.7% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $169.0K | 4,179 | 0.7% |
| Codexis Inc(CDXS) | COM | 192005106 | $166.0K | 5,315 | 0.7% |
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $164.0K | 22,625 | 0.7% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $163.0K | 10,536 | 0.7% |
| Alector Inc(ALEC) | COM | 014442107 | $161.0K | 7,799 | 0.7% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $159.0K | 2,400 | 0.7% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $156.0K | 69,015 | 0.6% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $154.0K | 39,675 | 0.6% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $153.0K | 6,913 | 0.6% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $151.0K | 29,175 | 0.6% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $150.0K | 9,949 | 0.6% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $147.0K | 6,844 | 0.6% |
| Annexon Inc(ANNX) | COM | 03589W102 | $139.0K | 12,078 | 0.6% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $118.0K | 27,150 | 0.5% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $97.0K | 24,298 | 0.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $72.0K | 4,304 | 0.3% |
| Boise Cascade Co del(BCC) | COM | 09739D100 | $2.6K | 36,782 | 0.0% |
| Gold Fields LTD(EDG) | SPONSORED ADR | 38059T106 | $2.6K | 235,709 | 0.0% |